Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

While mutations in the KRAS oncogene are among the most prevalent in human cancer, there are few successful treatments to target these tumors. It is also likely that heterogeneity in KRAS -mutant tumor biology significantly contributes to the response to therapy. We hypothesized that the presence of...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 35; no. 24; pp. 3209 - 3216
Main Authors Schabath, M B, Welsh, E A, Fulp, W J, Chen, L, Teer, J K, Thompson, Z J, Engel, B E, Xie, M, Berglund, A E, Creelan, B C, Antonia, S J, Gray, J E, Eschrich, S A, Chen, D-T, Cress, W D, Haura, E B, Beg, A A
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.06.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…